Detalhe da pesquisa
1.
Adoptive therapy with cytomegalovirus-specific cytotoxic T lymphocytes for refractory cytomegalovirus DNAemia and disease after allogeneic haematopoietic stem cell transplantation.
Br J Haematol
; 204(4): 1393-1401, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38168845
2.
PASS-ALL study of paediatric-inspired versus adult chemotherapy regimens on survival of high-risk Philadelphia-negative B-cell acute lymphoblastic leukaemia with allogeneic haematopoietic stem cell transplantation.
Br J Haematol
; 204(2): 628-637, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38050437
3.
Mini-dose methotrexate combined with methylprednisolone for the initial treatment of acute GVHD: a multicentre, randomized trial.
BMC Med
; 22(1): 176, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38664766
4.
Sorafenib plus triplet therapy with venetoclax, azacitidine and homoharringtonine for refractory/relapsed acute myeloid leukemia with FLT3-ITD: A multicenter phase 2 study.
J Intern Med
; 295(2): 216-228, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37899297
5.
Prognostic and therapeutic significance of microbial cell-free DNA in plasma of people with acute decompensation of cirrhosis.
J Hepatol
; 78(2): 322-332, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36309130
6.
Ruxolitinib versus basiliximab for steroid-refractory acute graft-versus-host disease: a retrospective study.
Ann Hematol
; 102(10): 2865-2877, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37474631
7.
Idarubicin plus BuCy versus BuCy conditioning regimens for intermediate-risk acute myeloid leukemia in first complete remission undergoing auto-HSCT: An open-label, multicenter, randomized phase 3 trial.
Am J Hematol
; 98(3): 408-412, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588387
8.
A phase 2 study of sorafenib combined with conventional therapies in refractory central nervous system leukemia.
Cancer
; 128(11): 2138-2147, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35315510
9.
Effect of sorafenib maintenance on Epstein-Barr virus and cytomegalovirus infections in patients with FLT3-ITD AML undergoing allogeneic hematopoietic stem cell transplantation: a secondary analysis of a randomized clinical trial.
BMC Med
; 20(1): 282, 2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36050712
10.
Intestinal microbiota score could predict survival following allogeneic hematopoietic stem cell transplantation.
Ann Hematol
; 101(6): 1283-1294, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35332375
11.
Cidofovir, a choice for salvage treatment of cytomegalovirus infection in patients with haploidentical hematopoietic stem cell transplantation.
Transpl Infect Dis
; 24(2): e13776, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34941004
12.
Upfront transplantation may have better outcomes than pretransplant cytoreductive therapy for treating patients with MDS-EB-1 or MDS-EB-2.
Int J Cancer
; 149(5): 1109-1120, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33899230
13.
Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial.
Lancet Oncol
; 21(9): 1201-1212, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32791048
14.
Ponatinib therapy in recurrent Philadelphia chromosome-positive central nervous system leukemia with T315I mutation after Allo-HSCT.
Int J Cancer
; 147(4): 1071-1077, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31785158
15.
A gut microbiota score predicting acute graft-versus-host disease following myeloablative allogeneic hematopoietic stem cell transplantation.
Am J Transplant
; 20(4): 1014-1027, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31605563
16.
Sorafenib Therapy Is Associated with Improved Outcomes for FMS-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(8): 1674-1681, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31009704
17.
Intestinal Microbiota Can Predict Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(10): 1944-1955, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31299215
18.
Two dose levels of rabbit antithymocyte globulin as graft-versus-host disease prophylaxis in haploidentical stem cell transplantation: a multicenter randomized study.
BMC Med
; 17(1): 156, 2019 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31401973
19.
Expansion of circulating extrafollicular helper T-like cells in patients with chronic graft-versus-host disease.
J Autoimmun
; 100: 95-104, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30878167
20.
Invasive fungal disease is associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplant: a single center, retrospective study.
Infection
; 47(2): 275-284, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30734248